Posted 03 September 2015
This article by Roni Caryn Rabin and published in the New York Times on 31 August 2015, refers to a study conducted by the National Institutes of Health, who randomly assigned participants to take a lutein/zeaxanthin supplement, a supplement of omega-3 long-chain polyunsaturated fatty acids with docosahexaenoic acid (DHA) and eicosapentaenoic acid (EHA), both or a placebo. The study recruited more than 3,500 subjects with an average age of 73.
The researchers evaluated the subjects’ cognitive function when they enrolled and then every two years. At the end of the study, the researchers did not find any differences among groups that had taken supplements and the placebo group.
Continue reading at the New York Times… Read the rest